pirfenidone has been researched along with Constriction, Pathological in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 3 (60.00) | 2.80 |
Authors | Studies |
---|---|
Fujiwara, Y; Fukunaga, S; Higashimori, A; Hirano, S; Hosomi, S; Kamata, N; Nadatani, Y; Nagami, Y; Ominami, M; Otani, K; Taira, K; Tanaka, F; Tanigawa, T; Watanabe, T | 1 |
Gao, B; Li, X; Ma, Y; Pan, J; Qian, H | 1 |
Guan, Y; Jiang, Z; Ma, L; Meng, W; Wang, J; Zhou, Y | 1 |
Hu, H; Li, F; Liu, F; Ma, W; Pan, Q; Ran, C; Wang, J; Yang, Q | 1 |
Chen, J; Coleman, JA; Durack, JC; Felsen, D; Fujimori, M; Kodama, H; Solomon, SB; Srimathveeravalli, G; Ueshima, E | 1 |
5 other study(ies) available for pirfenidone and Constriction, Pathological
Article | Year |
---|---|
Pirfenidone prevents esophageal stricture by inhibiting nucleotide binding oligomerization domain like receptor protein 3 inflammasome activation.
Topics: Animals; Carrier Proteins; Caspase 1; Constriction, Pathologic; Esophageal Stenosis; Fibrosis; Humans; Inflammasomes; Interleukin-1beta; NLR Family, Pyrin Domain-Containing 3 Protein; Nucleotides; Pyridones; Rats; Ulcer | 2022 |
Treatment of scarring central airway stenosis with pirfenidone: Case report.
Topics: Bronchi; Bronchoscopy; Cicatrix; Constriction, Pathologic; Humans; Stents; Tomography, X-Ray Computed; Trachea | 2022 |
Inhibition of Ureteral Stricture by Pirfenidone-Loaded Nanoparticle-Coated Ureteral Stents with Slow-Release Pirfenidone.
Topics: Animals; Constriction, Pathologic; Iatrogenic Disease; Rabbits; Stents; Ureter; Ureteral Obstruction | 2022 |
A Novel Rabbit Model for Benign Biliary Stricture Formation and the Effects of Medication Infusions on Stricture Formation.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Antineoplastic Agents; Biliary Tract Diseases; Constriction, Pathologic; Disease Models, Animal; Drug Evaluation, Preclinical; Pyridones; Rabbits; Secondary Prevention; Sirolimus; Vasodilator Agents | 2018 |
Macrophage-secreted TGF-β
Topics: Animals; BALB 3T3 Cells; Cicatrix; Collagen; Constriction, Pathologic; Female; Fibroblasts; Macrophages; Mice; Models, Animal; Pyridones; RAW 264.7 Cells; Sus scrofa; Transforming Growth Factor beta1; Ureter; Ureteral Diseases; Wound Healing | 2019 |